Monday: Manfred Horst on MSD, Biosimilars, KEYTRUDA and Merck & Co.’s rich history
Tuesday: An Insider’s experience at the iGEM Giant Boston Jamboree 2015
Wednesday: Sorry CRISPR, you’ll have to wait another year to win a Nobel Prize!
Thursday: The Future Biotech Lab Bench: My experience of the cutting edge-tech at LABVOLUTION
Friday: Alzheimer’s Disease: Phase III breakthrough Tau-therapy earns Scottish Biotech €120M